Page last updated: 2024-10-25

deferoxamine and Cryptococcosis

deferoxamine has been researched along with Cryptococcosis in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Cryptococcosis: Fungal infection caused by genus CRYPTOCOCCUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chayakulkeeree, M1
Tangkoskul, T1
Waywa, D1
Tiengrim, S1
Pati, N1
Thamlikitkul, V1
Tangen, KL1
Jung, WH1
Sham, AP1
Lian, T1
Kronstad, JW1

Other Studies

2 other studies available for deferoxamine and Cryptococcosis

ArticleYear
Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
    Journal de mycologie medicale, 2020, Volume: 30, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Deferasiro

2020
The iron- and cAMP-regulated gene SIT1 influences ferrioxamine B utilization, melanization and cell wall structure in Cryptococcus neoformans.
    Microbiology (Reading, England), 2007, Volume: 153, Issue:Pt 1

    Topics: Animals; Cell Wall; Cryptococcosis; Cryptococcus neoformans; Cyclic AMP; Deferoxamine; Ferric Compou

2007